Partnering plays a strategic role in executing our R&D strategy, evolving our portfolio and growth. Our goal in partnering is to discover, develop and deliver transformational medicines to patients by bringing innovative science, research and technology together with our capabilities and expertise.
Why Partner With Us
With a long history of successful scientific and commercial collaborations that exhibit speed, collaboration, innovation, and strong partner relationships, research and development (R&D) is at the center of our strategy. With more than 50 compounds in development and a network of research facilities around the globe, we've been recognized as one of the premier R&D organizations in the industry.
External innovation and partnering are critical drivers of out strategy and have brought significant commercial success and pipeline growth. 60% of our current development pipeline is externally sourced and 12 of our 20 blockbuster drugs are derived from collaborations.
What We're Focused On
We are focused on discovering, developing and delivering innovative medicines that help patients prevail over serious diseases. We concentrate on our core therapeutic areas and are pursuing multiple drug platforms across these areas with a goal of transforming patients' lives through science.
Working to #HackCancer
Contact us about partnering
Start the partnership process. Please send NON-CONFIDENTIAL information about your opportunity to one of the individuals below based on your area of interest:
Oncology - Solid Tumors: BD-Onc@bms.com
Hematology & Cell Therapy: BD-HemaCT@bms.com
Neuroscience & Cardiovascular: BD-NeuroCV@bms.com
Fibrosis & Immunology: BD-FibImm@bms.com
Translational Medicine: BD-PDxBiomarkers@bms.com
Research Enabling Technologies: BD-RET@bms.com
Digital Health Initiatives: BD-DHI@bms.com